20 unknown. 20 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 20 | Unknown 20 |
| Phase 2 | 2 | Unknown 2 |
Follow Bladder Cancer: new trials by email Literature Review of Bladder Cancer trials Research Report on Bladder Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Multicentral Preventive Antibiotics With Cystectomy Within Enhanced Recovery After Surgery Meropenem 1000 mg, Amoxicillin+clavulanic acid 1200 mg or Cefuroksim 1500mg - Bladder Cancer | Phase 3 | Unknown | N.N. Petrov National Medical Research Center of Oncology | 98 | 2022-02-02 | 2022-05-31 |
| Fast Track Protocol After Radical Cystectomy and Urinary Diversion: A Randomised Controlled Trial. Fast Track Protocol - Bladder Cancer | Phase 3 | Unknown | Mansoura University | 200 | 2021-01-15 | 2021-06-25 |
| Electromotive Mitomycin-C (EMDA-MMC) in Preventing Recurrences in High-risk Non-muscle-invasive Bladder Cancer BCG instillation therapy, Sequential BCG and EMDA mitomycin C - Bladder Cancer | Phase 3 | Unknown | Turku University Hospital | 300 | 2018-10-26 | 2021-04-01 |
| Assessment of BladderLight SurvEILlance BladderLight® - Bladder Cancer | Phase 2 / Phase 3 | Unknown | Cambridge University Hospitals NHS Foundation Trust | 2100 | 2018-02-01 | 2018-02-09 |
| A Study of Comparing Effects of Thulium Laser en Bloc Resection and Electrical Transurethral Resection of the Non-muscle Invasive Bladder Cancer Thulium Laser en Bloc Resection of bladder tumor, Electrical transurethral resection of bladder tumor - Bladder Cancer | Phase 3 | Unknown | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 172 | 2017-01-01 | 2016-11-01 |
| Pemetrexed Maintenance in Patients With Urothelial Carcinoma Who Completed First Line Platinum-based Chemotherapy pemetrexed, Folic Acid, Vitamin B12 Injection - Bladder Cancer, Ureter Cancer | Phase 3 | Unknown | Asan Medical Center | 74 | 2017-01-01 | 2017-06-21 |
| Four Cycles Versus Six Cycles of Cisplatin-based Chemotherapy in Metastatic Urothelial Carcinoma Treatment duration of cisplatin based chemotherapy - Bladder Cancer, Ureter Cancer | Phase 3 | Unknown | Asan Medical Center | 330 | 2016-09-01 | 2017-09-28 |
| Adjuvant Chemotherapy Following Radical Cystectomy to Treat Locally Advanced Bladder Cancer Gemcitabine, Cisplatin - Bladder Cancer | Phase 3 | Unknown | Southwest Hospital, China | 200 | 2014-03-01 | 2014-02-28 |
| Adding Mitomycin to BCG as Adjuvant Intravesical Therapy for High-risk Non-Muscle-invasive Bladder Cancer Bacillus of Calmette-Guerin (BCG), Mitomycin (MM) - Bladder Cancer | Phase 3 | Unknown | University of Sydney | 501 | 2013-07-01 | 2023-06-18 |
| Fluorescence Cystoscopy and Optimized MMC in Recurrent Bladder Cancer (FinnBladder 9) white light TUR-BT, blue light TUR-BT, optimized MMC - Bladder Cancer | Phase 3 | Unknown | Turku University Hospital | 400 | 2012-12-01 | 2023-04-13 |
| Efficacy of Diclofenac BCG Irrigations Abitren, Placebo - Bladder Cancer | Phase 3 | Unknown | Carmel Medical Center | 100 | 2012-05-01 | 2012-05-22 |
| Study of the Efficacy of Maintenance Therapy Using Uracil-tegafur (UFT) or Bacille Calmette-Guerin (BCG) for the Prevention of Recurrences of Superficial Bladder Cancer (EMBARK Study) Bacille Calmette-Guerin, uracil-tegafur - Bladder Cancer | Phase 3 | Unknown | Urological Oncology Council of Northern Tokyo | 288 | 2010-01-01 | 2011-03-24 |
| Hyperthermia and Mitomycin C, Bacillus Calmette-Guerin, or Standard Therapy as Second-Line Therapy in Treating Patients With Recurrent Bladder Cancer BCG solution, recombinant interferon alfa, epirubicin hydrochloride - Bladder Cancer | Phase 3 | Unknown | Cancer Research Campaign Clinical Trials Centre | 242 | 2009-10-01 | 2013-08-12 |
| A Double Blind Randomised Study of Lapatinib and Placebo in Metastatic TCC of the Urothelium lapatinib ditosylate, Placebo - Bladder Cancer | Phase 2 / Phase 3 | Unknown | Queen Mary University of London | 204 | 2009-03-01 | 2015-04-15 |
| Hyperbaric Oxygen Therapy in Treating Long-Term Gastrointestinal Adverse Effects Caused by Radiation Therapy in Patients With Pelvic Cancer questionnaire administration, gastrointestinal complications management/prevention, quality-of-life assessment - Bladder Cancer, Cervical Cancer | Phase 3 | Unknown | Royal Marsden NHS Foundation Trust | 75 | 2009-01-01 | 2011-07-15 |
| Different Factors Affecting Patients With Newly Diagnosed Bladder Cancer selenium, vitamin E, biopsy - Bladder Cancer | Phase 3 | Unknown | University Hospital Birmingham | 3400 | 2005-12-01 | 2014-01-10 |
| Selenium and Vitamin E in Preventing Cancer Progression and Recurrence in Patients With Early-Stage Bladder Cancer selenium, vitamin E, chemoprevention - Bladder Cancer | Phase 3 | Unknown | University of Birmingham | 515 | 2005-12-01 | 2014-01-10 |
| Cisplatin and Gemcitabine Compared With Observation in Treating Patients Who Have Undergone Surgery for Bladder Cancer cisplatin, gemcitabine hydrochloride, adjuvant therapy - Bladder Cancer | Phase 3 | Unknown | Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, Italy | 700 | 2001-09-01 | 2013-12-18 |
| Adjuvant Versus Progression-Triggered Gemcitabine Monotherapy for Locally Advanced Bladder Cancer gemcitabine - Bladder Cancer, Carcinoma, Transitional Cell | Phase 3 | Unknown | Association of Urologic Oncology (AUO) | 178 | 2000-07-01 | 2006-09-27 |
| Surgery With or Without Chemotherapy in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer valrubicin, conventional surgery - Bladder Cancer | Phase 3 | Unknown | Anthra Pharmaceuticals | 300 | 1996-12-01 | 2013-11-06 |
Urinary Bladder Neoplasms (20) · Carcinoma, Transitional Cell (3) · Recurrence (3) · Ureteral Neoplasms (2) · Carcinoma, Ovarian Epithelial (1) · Colorectal Neoplasms (1) · Endometrial Neoplasms (1) · Hematuria (1) · Ovarian Neoplasms (1) · Prostatic Neoplasms (1) · Radiation Injuries (1) · Rectal Neoplasms (1) · Sarcoma (1) · Testicular Germ Cell Tumor (1) · Testicular Neoplasms (1)
Female Urogenital Diseases (20) · Female Urogenital Diseases and Pregnancy Complications (20) · Male Urogenital Diseases (20) · Neoplasms (20) · Neoplasms by Site (20) · Urinary Bladder Diseases (20) · Urogenital Diseases (20) · Urogenital Neoplasms (20) · Urologic Diseases (20) · Urologic Neoplasms (20) · Carcinoma (4) · Neoplasms by Histologic Type (4) · Neoplasms, Glandular and Epithelial (4) · Disease Attributes (3) · Pathologic Processes (3)
Gemcitabine (3) · BCG Connaught (2) · BCG Vaccine (2) · Chemoprevention (2) · Cisplatin (2) · Mitomycin (2) · Selenium (2) · Vitamin E (2) · Amoxicillin-Potassium Clavulanate Combination (1) · Biopsy (1) · Calcium Dobesilate (1) · Chemotherapy, Adjuvant (1) · Cryopreservation (1) · Dexamethasone (1) · Diathermy (1)
Asan Medical Center (2) · Turku University Hospital (2) · Anthra Pharmaceuticals (1) · Association of Urologic Oncology (AUO) (1) · Cambridge University Hospitals NHS Foundation Trust (1) · Cancer Research Campaign Clinical Trials Centre (1) · Carmel Medical Center (1) · Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, Italy (1) · Mansoura University (1) · N.N. Petrov National Medical Research Center of Oncology (1) · Queen Mary University of London (1) · Royal Marsden NHS Foundation Trust (1) · Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine (1) · Southwest Hospital, China (1) · University Hospital Birmingham (1)
United Kingdom (6) · Finland (2) · South Korea (2) · Australia (1) · Canada (1) · China (1) · Egypt (1) · Germany (1) · Italy (1) · Japan (1) · Russia (1) · United States (1)
Ahmed Lashin, Dr. (1) · Ahmed Mosbah, Prof. (1) · Camillo F. Pollera, MD (1) · Dickon Hayne (1) · Eero Kaasinen, Md, PhD (1) · Jae-Lyun Lee, MD, PhD (1) · Jae-Lyun Lee, MD., PhD. (1) · John Kelly, MD (1) · John R. Yarnold, MD, FRCR (1) · K. K. Cheng, MD (1) · Mahmoud Laymon, Lecturer. (1) · Mariya Berkut, PhD (1) · Maurice Zeegers (1)
PMID 11001674, PMID 11844814, PMID 1607913, PMID 16330205, PMID 16389183, PMID 16849761, PMID 18024869, PMID 18685414, PMID 19687335, PMID 23835707, PMID 24055428, PMID 25720673, PMID 26001531, PMID 26845426, PMID 30274699, PMID 35094962, PMID 39355793